122 related articles for article (PubMed ID: 28766965)
1. MAP2 IHC detection: a marker of antigenicity in CNS tissues.
D'Andrea MR; Howanski RJ; Saller CF
Biotech Histochem; 2017; 92(5):363-373. PubMed ID: 28766965
[TBL] [Abstract][Full Text] [Related]
2. Class III beta-tubulin isotype (beta III) in the adrenal medulla: III. Differential expression of neuronal and glial antigens identifies two distinct populations of neuronal and glial-like (sustentacular) cells in the PC12 rat pheochromocytoma cell line maintained in a Gelfoam matrix system.
Katsetos CD; Herman MM; Balin BJ; Vinores SA; Hessler RB; Arking EJ; Karkavelas G; Frankfurter A
Anat Rec; 1998 Mar; 250(3):351-65. PubMed ID: 9517852
[TBL] [Abstract][Full Text] [Related]
3. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease.
D'Andrea MR; Nagele RG
Biotech Histochem; 2002 Mar; 77(2):95-103. PubMed ID: 12083391
[TBL] [Abstract][Full Text] [Related]
4. Distribution of phosphate-independent MAP2 epitopes revealed with monoclonal antibodies in microwave-denatured human nervous system tissues.
Trojanowski JQ; Schuck T; Schmidt ML; Lee VM
J Neurosci Methods; 1989 Aug; 29(2):171-80. PubMed ID: 2475725
[TBL] [Abstract][Full Text] [Related]
5. Distribution of MAP2 in dendritic spines and its colocalization with actin. An immunogold electron-microscope study.
Morales M; Fifkova E
Cell Tissue Res; 1989 Jun; 256(3):447-56. PubMed ID: 2743390
[TBL] [Abstract][Full Text] [Related]
6. Effects of autolysis and prolonged formalin fixation on histomorphology and immunohistochemistry of normal canine brain tissue: an experimental study.
Koehler JW; Miller AD; Rissi DR
J Vet Diagn Invest; 2024 Mar; 36(2):169-176. PubMed ID: 38212877
[TBL] [Abstract][Full Text] [Related]
7. Transient loss of microtubule-associated protein 2 immunoreactivity after moderate brain injury in mice.
Huh JW; Raghupathi R; Laurer HL; Helfaer MA; Saatman KE
J Neurotrauma; 2003 Oct; 20(10):975-84. PubMed ID: 14588114
[TBL] [Abstract][Full Text] [Related]
8. Differential localization of high- and low-molecular-weight variants of microtubule-associated protein 2 in the developing rat telencephalon.
Fujimori K; Takauji R; Tamamaki N
J Comp Neurol; 2002 Aug; 449(4):330-42. PubMed ID: 12115669
[TBL] [Abstract][Full Text] [Related]
9. MAP2 and neurogranin as markers for dendritic lesions in CNS injury. An immunohistochemical study in the rat.
Li GL; Farooque M; Lewen A; Lennmyr F; Holtz A; Olsson Y
APMIS; 2000 Feb; 108(2):98-106. PubMed ID: 10737454
[TBL] [Abstract][Full Text] [Related]
10. Microtubule-Associated Protein 2 Expression in Canine Glioma.
Demeter EA; Frank C; Rissi DR; Porter BF; Miller AD
Front Vet Sci; 2019; 6():395. PubMed ID: 31803765
[TBL] [Abstract][Full Text] [Related]
11. Chronic restraint stress alters the expression and distribution of phosphorylated tau and MAP2 in cortex and hippocampus of rat brain.
Yan J; Sun XB; Wang HQ; Zhao H; Zhao XY; Xu YX; Guo JC; Zhu CQ
Brain Res; 2010 Aug; 1347():132-41. PubMed ID: 20513368
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic-ischemic injury acutely disrupts microtubule-associated protein 2 immunostaining in neonatal rat brain.
Malinak C; Silverstein FS
Biol Neonate; 1996; 69(4):257-67. PubMed ID: 8724654
[TBL] [Abstract][Full Text] [Related]
13. Microtubule-associated protein 2 levels decrease in hippocampus following traumatic brain injury.
Taft WC; Yang K; Dixon CE; Hayes RL
J Neurotrauma; 1992; 9(3):281-90. PubMed ID: 1474611
[TBL] [Abstract][Full Text] [Related]
14. Developmental changes of MAP2 immunoreactivity in the hippocampus proper and dentate gyrus of the rat.
Biranowska J; Berdel B; Ludkiewicz B; Dziewiatkowski J; Jagalska-Majewska H; Moryś J
Folia Neuropathol; 2000; 38(1):1-6. PubMed ID: 11057027
[TBL] [Abstract][Full Text] [Related]
15. Expression and distribution of microtubule-associated protein 2 (MAP2) in neuroblastoma and primary neuronal cells.
Fischer I; Shea TB; Sapirstein VS; Kosik KS
Brain Res; 1986 Feb; 390(1):99-109. PubMed ID: 3512042
[TBL] [Abstract][Full Text] [Related]
16. Distribution of map2 in hippocampus and cerebellum of young and old rats by quantitative immunohistochemistry.
Di Stefano G; Casoli T; Fattoretti P; Gracciotti N; Solazzi M; Bertoni-Freddari C
J Histochem Cytochem; 2001 Aug; 49(8):1065-6. PubMed ID: 11457938
[TBL] [Abstract][Full Text] [Related]
17. Effect of acrylamide on the distribution of microtubule-associated proteins (MAP1 and MAP2) in selected regions of rat brain.
Chauhan NB; Spencer PS; Sabri MI
Mol Chem Neuropathol; 1993 Apr; 18(3):225-45. PubMed ID: 8507302
[TBL] [Abstract][Full Text] [Related]
18. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
[TBL] [Abstract][Full Text] [Related]
19. Microtubule-associated protein MAP2 expression in olfactory bulb in schizophrenia.
Rioux L; Ruscheinsky D; Arnold SE
Psychiatry Res; 2004 Aug; 128(1):1-7. PubMed ID: 15450909
[TBL] [Abstract][Full Text] [Related]
20. Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury.
Posmantur RM; Kampfl A; Taft WC; Bhattacharjee M; Dixon CE; Bao J; Hayes RL
J Neurotrauma; 1996 Mar; 13(3):125-37. PubMed ID: 8965322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
